[1]闵敏,综述,邱艳霞,等.粥样硬化性肾动脉狭窄介入适应证的探讨[J].心血管病学进展,2016,(3):231-234.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.004]
　MIN Min,QIU Yanxia,JIA Nan.Indications of Endovascular Procedure for Atherosclerotic Renal Artery Stenosis[J].Advances in Cardiovascular Diseases,2016,(3):231-234.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.004]
点击复制

粥样硬化性肾动脉狭窄介入适应证的探讨()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2016年3期
页码:
231-234
栏目:
主题综述
出版日期:
2016-06-20

文章信息/Info

Title:
Indications of Endovascular Procedure for Atherosclerotic Renal Artery Stenosis
作者:
闵敏; 综述; 邱艳霞; 贾楠; 审校
深圳第四人民医院心内科, 广东 深圳 518000
Author(s):
MIN Min; QIU Yanxia; JIA Nan
Department of Cardiology,The Fourth People's Hospital of Shenzhen,Shenzhen 518000,Guangdong,China
关键词:
粥样硬化性肾动脉狭窄;  介入治疗;  适应证
Keywords:
Atherosclerotic renal artery stenosis;  Endovascular procedure;  Indications
分类号:
R54
DOI:
10.16806/j.cnki.issn.1004-3934.2016.03.004
文献标志码:
A
摘要:
近期发表的大型随机临床试验结果显示与单纯药物治疗相比,粥样硬化性肾动脉狭窄介入加药物治疗未发现额外获益; 但临床实践过程中发现部分介入治疗可缓解肾动脉狭窄患者的症状及改善预后。是否适应证的选择缺陷是导致肾动脉介入治疗不能发挥良好疗效的原因?如何能找出从介入治疗获益的肾动脉狭窄患者,关键是进一步细化肾动脉狭窄介入治疗适应证。现分析对粥样硬化性肾动脉狭窄介入治疗效果有预测价值的检测项目,有助于术者优化选择治疗人群,提高肾动脉介入治疗临床获益。
Abstract:
Results from recent trials fail to demonstrate the major benefits of endovascular stenting for renal artery stenosis in addition to optimal medical therapy. But we found that part of the interventional therapy can relieve the symptoms and improve the prognosis of patients with renal artery stenosis in clinical. Whether defects of the indications led to failure of renal artery intervention. How can we find out the benefit from interventional therapy of renal arterial stenosis? The key is to further refine indications of endovascular procedure. This paper analyzes the predictive value of some test items for endovascular procedure, to optimize indications and improve clinical benefits of interventional therapy.

参考文献/References:

[1] Safian RD,Textor SC. Renal-artery stenosis[J].N Engl J Med,2001,344(6):431-442.
[2] Henry M, Benjelloun A, Henry I.Renal angioplasty and stenting: is it still indicated after ASTRAL and STAR studies?[J].J Cardiovasc Surg(Torino),2010,51(5):701-720.
[3] Bax L,Woittiez AJ,Kouwenberg HJ,et al.Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial[J].Ann Intern Med,2009,150(12):840-848.
[4] Wheatley K,Ives N,Gray R,et al.Revascularization versus medical therapy for renal-artery stenosis[J].N Engl J Med,2009,361(20):1953-1962.
[5] Kumbhani DJ, Bavry AA, Harvey JE,et al.Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials[J].Am Heart J,2011,161(3):622-630.
[6] Cooper CJ,Murphy TP,Cutlip DE,et al.Stenting and medical therapy for atherosclerotic renal-artery stenosis[J].N Engl J Med,2014,370(1):13-22.
[7] 蒋雄京,彭猛.肾动脉硬化病变心血管结局研究后时代如何治疗粥样硬化性肾动脉狭窄[J].中华高血压杂志,2014,8(22):714-715.
[8] Kalra PA. Angioplasty and Stent for Renal Artery Lesions(ASTRAL): stenting makes no difference in renal artery disease[C]. 2008 SCAI-ACCi2 joint meeting,Chicago, USA,2008.
[9] Weinberg MD,Olin JW.Stenting for atherosclerotic renal artery stenosis:one poorly designed trial after another[J].Cleve Clin J Med,2010,77(3):164-171.
[10] Parikh SA, Shishehbor MH, Gray BH, et al. SCAI expert consensus statement for renal artery stenting appropriate use[J].Catheter Cardiovasc Interv,2014,84:1163-1171.
[11] 程庆砾,蒋雄京,陈兵,等.老年动脉粥样硬化性肾动脉狭窄诊治的中国专家共识[J].中华老年医学杂志,2010,29(4):264-270.
[12] Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultra-sonography to predict the outcome of therapy for renal-artery stenosis[J].N Engl J Med,2001,344(6):410-417.
[13] Zeller T, Müller C, Frank U,et al. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis[J]. Catheter Cardiovasc Interv,2003,58(4):510-515.
[14] de Bruyne B, Bartunek J, Sys SU,et al. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia[J]. Circulation,1995,92(1):39-46.
[15] Mahmud E, Smith TW, Palakodeti V,et al. Renal frame count and renal blush grade: quantitative measures that predict the success of renal stenting in hypertensive patients with renal artery stenosis[J].JACC Cardiovasc Interv,2008,1(3):286-292.
[16] Mitchell JA, Subramanian R, White CJ, et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement:renal fractional flow reserve[J].Catheter Cardiovasc Interv,2007,69(5):685-689.
[17] Soveri I,Berg UB, Björk J,et al. Measuring GF R:a systematic review[J].Am J Kidney Dis,2014,64(3):411-424.
[18] 虞倩,王蓓丽.肾小球滤过率的测定方法及其临床应用[J].检验医学,2015,30(7):674-679.
[19] Kalra PA, Chrysochou C, Green D, et al.The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease[J]. Catheter Cardiovasc Interv,2010,75:1-10.
[20] Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy[J].Am J Hypertens,2010,23(11):1159-1169.
[21] Textor SC. Atherosclerotic renal artery stenosis: flaws in estimated glomerular filtration rate and the problem of progressive kidney injury[J].Circ Cardiovasc Interv,2011,4(3):213-215.
[22] 李晓波,李玉琼,陶波,等.肾动态显像测定的肾小球滤过率对年轻患者肾动脉狭窄诊断和肾功能的评估价值[J].中华高血压杂志,2012,20(12):1144-1150.
[23] 贾楠,李晓波,何瑞青,等.分侧肾小球滤过率用于筛选肾动脉狭窄介入治疗适应证[J].中华高血压杂志,2014,22(4):353-359.
[24] Silva JA, Chan AW, White CJ, et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis[J]. Circulation,2005,111(3):328-333.
[25] Dieter RS, Darki A, Nanjundappa A, et al. Usefulness of wide pulse pressure as a predictor of poor outcome after renal artery angioplasty and stenting[J]. Am J Cardiol,2009,104(5):732-734.

相似文献/References:

[1]朱静怡,迟迪,刘向兰,等.主动脉窦瘤破裂的介入治疗进展[J].心血管病学进展,2015,(5):538.[doi:10.3969/j.issn.1004-3934.2015.05.004]
　ZHU Jingyi,CHI Di,LIU Xianglan,et al.Progress in Transcatheter Interventional Treatment of Ruptured Sinus of Valsalva Aneurysm[J].Advances in Cardiovascular Diseases,2015,(3):538.[doi:10.3969/j.issn.1004-3934.2015.05.004]
[2]龙愉良,周达新.心脏瓣膜疾病介入治疗进展[J].心血管病学进展,2015,(5):542.[doi:10.3969/j.issn.1004-3934.2015.05.005]
　LONG Yuliang,ZHOU Daxin.Progress of Interventional Therapy for Cardiac Valve Disease[J].Advances in Cardiovascular Diseases,2015,(3):542.[doi:10.3969/j.issn.1004-3934.2015.05.005]

备注/Memo

备注/Memo:
作者简介:闵敏(1977—),副主任医师,硕士,主要从事高血压及外周血管疾病研究。Email:waikeyisheng0366@163.com 通信作者:贾楠(1973—),副主任医师,博士,主要从事高血压与外周血管疾病研究。Email:jiananchina@hotmail.com
更新日期/Last Update: 2016-05-25